Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $17.21.
A number of research firms recently issued reports on BTSG. Mizuho boosted their target price on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Guggenheim boosted their target price on shares of BrightSpring Health Services from $15.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. KeyCorp began coverage on shares of BrightSpring Health Services in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Wells Fargo & Company boosted their target price on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, UBS Group boosted their target price on shares of BrightSpring Health Services from $16.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th.
Get Our Latest Stock Analysis on BTSG
Insider Buying and Selling
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Virtu Financial LLC purchased a new stake in BrightSpring Health Services during the 3rd quarter valued at about $522,000. Geode Capital Management LLC grew its stake in BrightSpring Health Services by 0.6% during the 3rd quarter. Geode Capital Management LLC now owns 1,304,214 shares of the company’s stock valued at $19,150,000 after acquiring an additional 7,750 shares in the last quarter. Barclays PLC grew its stake in BrightSpring Health Services by 22.2% during the 3rd quarter. Barclays PLC now owns 393,725 shares of the company’s stock valued at $5,780,000 after acquiring an additional 71,633 shares in the last quarter. State Street Corp grew its stake in BrightSpring Health Services by 7.4% during the 3rd quarter. State Street Corp now owns 1,239,628 shares of the company’s stock valued at $18,198,000 after acquiring an additional 85,464 shares in the last quarter. Finally, Verition Fund Management LLC grew its stake in BrightSpring Health Services by 34.2% during the 3rd quarter. Verition Fund Management LLC now owns 132,918 shares of the company’s stock valued at $1,951,000 after acquiring an additional 33,890 shares in the last quarter.
BrightSpring Health Services Price Performance
Shares of BTSG opened at $19.05 on Thursday. The firm has a market capitalization of $3.32 billion and a PE ratio of -74.77. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $20.25. The company’s fifty day moving average price is $16.51 and its 200-day moving average price is $13.42.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The company had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.72 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. BrightSpring Health Services’s revenue was up 28.8% compared to the same quarter last year. On average, equities research analysts predict that BrightSpring Health Services will post 0.59 EPS for the current year.
About BrightSpring Health Services
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also
- Five stocks we like better than BrightSpring Health Services
- How to Start Investing in Real Estate
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to buy stock: A step-by-step guide for beginners
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Euro STOXX 50 Index?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.